ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Sudhir Sundaresan
Joel D. Cooper
G. Alexander Patterson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sundaresan, S.
Right arrow Articles by Patterson, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sundaresan, S.
Right arrow Articles by Patterson, G. A.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1995;60:1341-1346
© 1995 The Society of Thoracic Surgeons

Original Articles: General Thoracic

Prevalence and Outcome of Bronchiolitis Obliterans Syndrome After Lung Transplantation

Sudhir Sundaresan, MD, Elbert P. Trulock, MD, Thallachallour Mohanakumar, PhD, Joel D. Cooper, MD, G. Alexander Patterson, MD The Washington University Lung Transplant Group

Divisions of Cardiothoracic Surgery and General Surgery, Department of Surgery, and Division of Respiratory and Critical Care, Department of Medicine, Washington University School of Medicine, Barnes Hospital, St. Louis, Missouri

Background. Bronchiolitis obliterans syndrome (BOS) is the main cause of late morbidity and mortality in lung transplantation. This study was designed to accurately determine the prevalence of this syndrome of chronic lung allograft dysfunction (which is presumed to be due to chronic rejection).

Methods. A retrospective analysis was done of 212 consecutive lung transplantations performed at Barnes Hospital between July 1988 and March 1994 to characterize the prevalence and course of BOS. One hundred eighty-seven transplant recipients survived at least 3 months after transplantation, putting them at risk for BOS. Recipients free of BOS (group I) were distinguished from those with BOS (group II) based on the presence of declining spirometry (forced expiratory volume in 1 second persistently less than 80% of previous baseline) or histologic obliterative bronchiolitis in group II.

Results. There were 110 transplantations in group I (59%) and 77 in group II (41%). At follow-up, BOS was detected using the following criteria: declining forced expiratory volume in 1 second alone, 40 of 77 (52%); positive histologic results alone, 7 of 77 (9.1%); and both, 30 of 77 (38.9%). Declining spirometry was the most common initial sign of BOS onset (57 of 77, 74%). There were no differences between groups with respect to age, sex, indication for transplantation, or type of transplantation performed. The mortality rate was significantly higher with BOS (group II, 22 of 77 [28.6%] versus group I, 8 of 110 [7.3%]; p = 0.001) and was not related to either the type of transplantation performed or the indication for transplantation. Follow-up of group II (mean 35.1 months; range, 7.1 to 63.7 months) showed a delay until BOS onset (16.1 ± 1.2 months); when BOS was fatal, death ensued within 11.5 ± 2.4 months of its onset. Comparison of the first and last quartiles of recipients in this series (QTR1 versus QTR4, 53 patients in each) demonstrated a higher prevalence of BOS in QTR1 (24 with BOS of 43 at risk [55.8%] versus QTR4, 5 with BOS of 52 at risk [9.6%]; p < 0.001) and a worse BOS functional score in QTR1 (2.2 ± 0.2 versus QTR4, 0.8 ± 0.2; p = 0.007).

Conclusions. (1) Bronchiolitis obliterans syndrome is truly a clinical syndrome, not simply a pathologic entity; (2) BOS displays considerable latency in onset and progression; (3) lung transplant recipients must therefore be followed up for a sufficient interval to determine the actual prevalence and mortality rate of BOS; and (4) the prevalence and mortality rates of BOS are higher than previously appreciated, exceeding 50% and 40%, respectively.


Related Article

Discussion
Ann. Thorac. Surg. 1995 60: 1346-1347. [Extract] [Full Text]



This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
A. Bharat, E. Kuo, N. Steward, A. Aloush, R. Hachem, E. P. Trulock, G. A. Patterson, B. F. Meyers, and T. Mohanakumar
Immunological Link Between Primary Graft Dysfunction and Chronic Lung Allograft Rejection
Ann. Thorac. Surg., July 1, 2008; 86(1): 189 - 197.
[Abstract] [Full Text] [PDF]

Home page
 Am J Crit CareHome page
M.-K. Song, A. De Vito Dabbs, S. M. Studer, and S. E. Zangle
Course of Illness after the Onset of Chronic Rejection in Lung Transplant Recipients
Am. J. Crit. Care., May 1, 2008; 17(3): 246 - 253.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. D. Medoff, J. C. Wain, E. Seung, R. Jackobek, T. K. Means, L. C. Ginns, J. M. Farber, and A. D. Luster
CXCR3 and Its Ligands in a Murine Model of Obliterative Bronchiolitis: Regulation and Function.
J. Immunol., June 1, 2006; 176(11): 7087 - 7095.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
B. D. Medoff, E. Seung, J. C. Wain, T. K. Means, G. S.V. Campanella, S. A. Islam, S. Y. Thomas, L. C. Ginns, N. Grabie, A. H. Lichtman, et al.
BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation
J. Exp. Med., July 5, 2005; 202(1): 97 - 110.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
O. Brugiere, G. Thabut, H. Mal, A. Marceau, G. Dauriat, R. Marrash-Chahla, Y. Castier, G. Leseche, M. Colombat, and M. Fournier
Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome
Eur. Respir. J., May 1, 2005; 25(5): 813 - 819.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. M. Ramirez, S. Takagawa, M. Sekosan, H. A. Jaffe, J. Varga, and J. Roman
Smad3 Deficiency Ameliorates Experimental Obliterative Bronchiolitis in a Heterotopic Tracheal Transplantation Model
Am. J. Pathol., October 1, 2004; 165(4): 1223 - 1232.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. R. Hachem, M. M. Chakinala, R. D. Yusen, J. P. Lynch, A. A. Aloush, G. A. Patterson, and E. P. Trulock
The Predictive Value of Bronchiolitis Obliterans Syndrome Stage 0-p
Am. J. Respir. Crit. Care Med., February 15, 2004; 169(4): 468 - 472.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
B. V. Naidu, A. S. Farivar, B. Krishnadasan, S. M. Woolley, D. J. Grainger, E. D. Verrier, and M. S. Mulligan
Broad-spectrum chemokine inhibition ameliorates experimental obliterative bronchiolitis
Ann. Thorac. Surg., April 1, 2003; 75(4): 1118 - 1122.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. Pietrantoni, O. A. Minai, N. C. Yu, J. R. Maurer, M. T. Haug III, A. C. Mehta, and A. C. Arroliga
Respiratory Failure and Sepsis Are the Major Causes of ICU Admissions and Mortality in Survivors of Lung Transplants
Chest, February 1, 2003; 123(2): 504 - 509.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
O. Brugiere, F. Pessione, G. Thabut, H. Mal, G. Jebrak, G. Leseche, and M. Fournier
Bronchiolitis Obliterans Syndrome After Single-Lung Transplantation* : Impact of Time to Onset on Functional Pattern and Survival
Chest, June 1, 2002; 121(6): 1883 - 1889.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
W. Briest
Do we have a new early marker of chronic transplant dysfunction now?
Cardiovasc Res, June 1, 2002; 54(3): 492 - 494.
[Full Text] [PDF]

Home page
 RadiologyHome page
M. J. Siegel, S. Bhalla, F. R. Gutierrez, C. Hildebolt, and S. Sweet
Post-Lung Transplantation Bronchiolitis Obliterans Syndrome: Usefulness of Expiratory Thin-Section CT for Diagnosis
Radiology, August 1, 2001; 220(2): 455 - 462.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
W. Y. Szeto, A. M. Krasinskas, D. Kreisel, S. H. Popma, and B. R. Rosengard
Donor antigen-presenting cells are important in the development of obliterative airway disease
J. Thorac. Cardiovasc. Surg., December 1, 2000; 120(6): 1070 - 1077.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. W. K. van den Berg, P. J. van Enckevort, E. M. TenVergert, D. S. Postma, W. van der Bij, and G. H. Koeter
Bronchiolitis Obliterans Syndrome and Additional Costs of Lung Transplantation
Chest, December 1, 2000; 118(6): 1648 - 1652.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J.-M. CHARPIN, M. STERN, D. GRENET, and D. ISRAËL-BIET
Insulinlike Growth Factor-1 in Lung Transplants with Obliterative Bronchiolitis
Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1991 - 1998.
[Abstract] [Full Text]

Home page
 ChestHome page
M. W. Gerbase, D. Dubois, C. Rothmeier, A. Spiliopoulos, W. Wunderli, and L. P. Nicod
Costs and Outcomes of Prolonged Cytomegalovirus Prophylaxis to Cover the Enhanced Immunosuppression Phase Following Lung Transplantation
Chest, November 1, 1999; 116(5): 1265 - 1272.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
M. A. Norgaard, C. B. Andersen, and G. Pettersson
Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?
Eur. J. Cardiothorac. Surg., September 1, 1999; 14(3): 311 - 318.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. M. Levine
Can Bronchiolitis Obliterans Syndrome Be Diagnosed By Phone From the Comfort of Home?
Chest, July 1, 1999; 116(1): 5 - 6.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. BOEHLER, X. H. BAI, M. LIU, S. CASSIVI, D. CHAMBERLAIN, A. S. SLUTSKY, and S. KESHAVJEE
Upregulation of T-Helper 1 Cytokines and Chemokine Expression in Post-transplant Airway Obliteration
Am. J. Respir. Crit. Care Med., June 1, 1999; 159(6): 1910 - 1917.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
R. I. Whyte, R. C. Robbins, J. Altinger, C. W. Barlow, R. Doyle, J. Theodore, and B. A. Reitz
Heart-lung transplantation for primary pulmonary hypertension
Ann. Thorac. Surg., April 1, 1999; 67(4): 937 - 941.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. N. HUSAIN, M. T. SIDDIQUI, E. W. HOLMES, A. J. CHANDRASEKHAR, M. MCCABE, R. RADVANY, and E. R. GARRITY Jr.
Analysis of Risk Factors for the Development of Bronchiolitis Obliterans Syndrome
Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 829 - 833.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
S. D. Cassivi, M. Liu, A. Boehler, A. K. Tanswell, A. S. Slutsky, and S. Keshavjee
TRANSGENE EXPRESSION AFTER ADENOVIRUS-MEDIATED RETRANSFECTION OF RAT LUNGS IS INCREASED AND PROLONGED BY TRANSPLANT IMMUNOSUPPRESSION
J. Thorac. Cardiovasc. Surg., January 1, 1999; 117(1): 1 - 8.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. C. Wain, C. D. Wright, D. P. Ryan, S. L. Zorb, D. J. Mathisen, and L. C. Ginns
Induction immunosuppression for lung transplantation with OKT3
Ann. Thorac. Surg., January 1, 1999; 67(1): 187 - 193.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. Jeppsson, C. Pellegrini, T. O'Brien, V. M. Miller, H. D. Tazelaar, and C. G.A. McGregor
Transbronchial gene transfer of endothelial nitric oxide synthase to transplanted lungs
Ann. Thorac. Surg., August 1, 1998; 66(2): 318 - 324.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
C. B. Huddleston, E. N. Mendeloff, A. H. Cohen, S. C. Sweet, D. T. Balzer, and G. B. Mallory Jr
Lung retransplantation in children
Ann. Thorac. Surg., July 1, 1998; 66(1): 199 - 204.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. J. Novick, L. W. Stitt, K. Al-Kattan, W. Klepetko, H.-J. Schafers, J.-P. Duchatelle, A. Khaghani, R. L. Hardesty, G. A. Patterson, and M. H. Yacoub
Pulmonary Retransplantation: Predictors of Graft Function and Survival in 230 Patients
Ann. Thorac. Surg., January 1, 1998; 65(1): 227 - 234.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. Trello, D. Williams, C. Keller, C Crim, R. Webster, and J. Ohar
Increased gelatinolytic activity in bronchoalveolar lavage fluid in stable lung transplant recipients
Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1978 - 1986.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
R. I. Whyte, S. J. Rossi, M. S. Mulligan, R. Florn, L. Baker, S. Gupta, F. J. Martinez, and J. P. Lynch III
Mycophenolate Mofetil for Obliterative Bronchiolitis Syndrome After Lung Transplantation
Ann. Thorac. Surg., October 1, 1997; 64(4): 945 - 948.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. J. Kroshus, V. R. Kshettry, K. Savik, R. John, M. I. Hertz, and R. M. Bolman III
RISK FACTORS FOR THE DEVELOPMENT OF BRONCHIOLITIS OBLITERANS SYNDROME AFTER LUNG TRANSPLANTATION
J. Thorac. Cardiovasc. Surg., August 1, 1997; 114(2): 195 - 202.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. E. Bavaria, R. Kotloff, H. Palevsky, B. Rosengard, J. R. Roberts, P. M. Wahl, N. Blumenthal, C. Archer, and L. R. Kaiser
BILATERAL VERSUS SINGLE LUNG TRANSPLANTATION FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
J. Thorac. Cardiovasc. Surg., March 1, 1997; 113(3): 520 - 528.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
R. S. Sundaresan, Y. Shiraishi, E. P. Trulock, J. Manley, J. Lynch, J. D. Cooper, and G. A. Patterson
CARDIAC AND PULMONARY REPLACEMENTSINGLE OR BILATERAL LUNG TRANSPLANTATION FOR EMPHYSEMA?
J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1485 - 1495.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
H. Reichenspurner, R. E. Girgis, R. C. Robbins, K. L. Yun, M. Nitschke, G. J. Berry, R. E. Morris, J. Theodore, and B. A. Reitz
Stanford Experience With Obliterative Bronchiolitis After Lung and Heart-Lung Transplantation
Ann. Thorac. Surg., November 1, 1996; 62(5): 1467 - 1472.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
E. Mayer, M. Dahm, U. Hake, F. X. Schmid, M. Pitton, I. Kupferwasser, S. Iversen, and H. Oelert
Mid-Term Results of Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension
Ann. Thorac. Surg., June 1, 1996; 61(6): 1788 - 1792.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.